Search Results - Thomas Friedemann

Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trial by Chun-li Lu, Liu-qing Yang, Xin-yan Jin, Thomas Friedemann, Yu-fei Li, Xue-han Liu, Xiao-ying Chen, Xiang-yun Zou, Bing-rui Zhang, Fu-xiang Wang, Yuan-long Lin, Yi-min Tang, Meng-li Cao, Ya-lin Jiang, You-fang Gao, Kui Liu, Zhen-gang Tao, Nicola Robinson, Nicola Robinson, Sven Schröder, Jian-ping Liu, Hong-zhou Lu

Connect to this object online.